Page 12 - 《中国药房》2026年1期
P. 12

云南省处方前置审核系统应用现状分析
                                                                       Δ


                                                                                       2, 9
                                                                                                 2, 10
                                                                    2, 7
                             2, 3
                                      2, 4
                                                                              2, 8
                                                          2, 6
          徐 帆    1, 2* ,尹文洁 ,李珂佳 ,李正富 ,陈 洁 ,邬梅仙 ,陈瑞祥 ,李松梅 ,张国文 ,李 特                                         2, 11
                                                2, 5
         (1.中国人民解放军联勤保障部队第920医院五华院区,昆明 650032;2.云南省药学会,昆明 650051;3.昆明
          医科大学附属延安医院药剂科,昆明 650051;4.昆明医科大学第二附属医院药剂科,昆明 650101;5.昭通市
          第一人民医院药剂科,云南 昭通 657000;6.昆明市第三人民医院药剂科,昆明 650041;7.昆明市官渡区人民
          医院药剂科,昆明 650211;8.云南省第三人民医院药剂科,昆明 650011;9.云南省中医医院药剂科,昆明
          650021;10.昆明医科大学第五附属医院/个旧市人民医院,云南 个旧 661000;11.云南省阜外心血管病医院/昆
          明医科大学附属心血管病医院药剂科,昆明 650102)

          中图分类号  R952;R197.32      文献标志码  A      文章编号  1001-0408(2026)01-0006-05
          DOI  10.6039/j.issn.1001-0408.2026.01.02

          摘   要  目的  调研云南省医疗机构处方前置审核系统的应用现状,评估其系统功能及管理能力,为推动合理用药提供实践依据。
          方法  对云南省二级及以上公立医疗机构进行系统应用情况调研;构建包含处方即时审查、处方关联审查、审核规则设定、循证信
          息支持、处方权限管理及系统应用管理6个方面共39项指标的能力成熟度评价体系,对其中已应用系统的医疗机构进行能力评
          估。结果  共回收有效问卷100份,其中37家医疗机构已启用处方前置审核系统,主要集中于三级医院。系统多采用模块化架构,
          通过应用程序接口及中间件嵌入医院信息系统,具备一定的实时处方风险识别能力。处方前置审核能力成熟度评价结果显示,系
          统在适应证、禁忌证、配伍禁忌等基础审核功能上表现良好,但在肠外营养处方和特定疾病药物用量审查、患者个体化特征识别及
          审核规则设定等方面仍存在不足,审方中心建设与制度管理亦不完善。结论  云南省处方前置审核系统总体应用率不高,系统功
          能与管理机制尚需进一步完善。建议加强低等级医疗机构的信息化建设投入,探索区域化统一审核机制,推动审方工作规范化、
          智能化发展。
          关键词  前置审核;处方审核;医疗机构;合理用药;能力成熟度

          Analysis of the application status of prescription pre-review systems in Yunnan province
                                                                             2, 7
                                                                                                          2, 9
                                                               2, 6
          XU Fan ,YIN Wenjie ,LI Kejia ,LI Zhengfu ,CHEN Jie ,WU Meixian ,CHEN Ruixiang ,LI Songmei ,
                              2, 3
                                        2, 4
                 1, 2
                                                                                              2, 8
                                                    2, 5
                                  2, 11
          ZHANG Guowen   2, 10 ,LI Te (1. Wuhua Campus, the 920th Hospital of Joint Logistics Support Force of PLA,
          Kunming  650032,  China;2.  Yunnan  Pharmaceutical  Association,  Kunming  650051,  China;3.  Dept.  of
          Pharmacy,  Yan’an  Hospital  Affiliated  to  Kunming  Medical  University,  Kunming  650051,  China;4.  Dept.  of
          Pharmacy, the Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China;5. Dept. of
          Pharmacy, Zhaotong First People’s Hospital, Yunnan Zhaotong 657000, China;6. Dept. of Pharmacy, Kunming
          Third People’s Hospital, Kunming 650041, China;7. Dept. of Pharmacy, Guandu District People’s Hospital of
          Kunming,  Kunming  650211,  China;8.  Dept.  of  Pharmacy,  the  Third  People’s  Hospital  of  Yunnan  Province,
          Kunming  650011,  China;9.  Dept.  of  Pharmacy,  Yunnan  Provincial  Hospital  of  Traditional  Chinese  Medicine,
          Kunming  650021,  China;10.  The  Fifth  Affiliated  Hospital  of  Kunming  Medical  University/Gejiu  People’s
          Hospital,  Yunnan  Gejiu  661000,  China;11.  Dept.  of  Pharmacy,  Yunnan  Fuwai  Cardiovascular  Hospital/
          Cardiovascular Hospital Affiliated to Kunming Medical University, Kunming 650102, China)

          ABSTRACT      OBJECTIVE  To  investigate  the  application  status  of  prescription  pre-review  systems  in  healthcare  institutions  of
          Yunnan province, evaluate their system functions and management capabilities, and provide a practical basis for promoting rational
          drug use. METHODS A questionnaire survey was conducted among public healthcare institutions at or above the secondary level in
          Yunnan province to investigate the deployment status of the systems. A capability maturity assessment framework was constructed,
          encompassing 6 dimensions and 39 indicators, including real-time prescription review, prescription correlation review, rule setting,
          evidence-based  information  support,  prescription  authority  management,  and  system  operation  management.  This  framework  was
                                                              then  used  to  evaluate  the  institutions  that  had  implemented  the
                                                              pre-review  systems.  RESULTS  A  total  of  100  valid
              Δ 基金项目 云南省科技厅科技计划项目(No.202101AY070001-
          293);云南省药学会科技计划项目(No.2024A01)                       questionnaires  were  collected,  with  37  institutions  having
             *第一作者 副主任药师,硕士生导师,博士。研究方向:临床药                    adopted  prescription  pre-review  systems,  mainly  tertiary
          学。E-mail:xu_fan@126.com                             hospitals.  The  system  predominantly  adopted  a  modular


          · 6 ·    China Pharmacy  2026 Vol. 37  No. 1                                 中国药房  2026年第37卷第1期
   7   8   9   10   11   12   13   14   15   16   17